Polypropylene monofilament suture and process for its manufacture

Claim 2

In a polypropylene monofilament suture manufacturing process in which an isotactic polypropylene is melt extruded to provide a monofilament and the solidified monofilament is subjected to stretching and annealing to provide the suture, the improvement which comprises equilibrating the stretched monofilament prior to annealing and thereafter annealing the stretched, equilibrated monofilament, equilibration of the stretched monofilament being achieved by storage of the monofilament for a period of at least about 2 days.

Claim 3

The process of claim 1 wherein equilibration of the stretched monofilament is achieved by storage of the monofilament for a period of at least about 3 days.

Claim 4

The process of claim 1 wherein equilibration of the stretched monofilament is achieved by storage of the monofilament for a period of at least about 4 days.

Claim 5

The process of claim 1 wherein the polypropylene possesses a weight average molecuIar weight of from about 294,000 to about 316,000 and a number average molecular weight of from about 78,400 to about 82,100.

Claim 6

The process of claim 4 wherein the polypropylene possesses a melt flow index in g/10 min of from about 2 to about 6.

Claim 7

The process of claim 5 wherein the polypropylene possesses a melt flow index in g/10 min of from about 3.5 to about 4.5

Claim 8

The process of claim 1 wherein the polypropylene is melt extruded at a temperature of from about 190° to about 230° C. to provide a monofilament and the solidified monofilament is stretched at a temperature of from about 80° to about 180° C. for from about 6 to about 7 times its initial length.

Claim 9

The process of claim 7 wherein for suture sizes of 4/0 and smaller, the solidified monofilament is stretched while being heated in an oven chamber maintained at a temperature of from about 90° to about 180° C.

Claim 10

The process of claim 7 wherein for suture sizes of 3/0 and larger, the solidified monofilament is stretched while being heated in water maintained at a temperature of from about 80° to abut 98° C.

Claim 11

The process of claim 1 wherein for suture sizes of 6/0 and smaller, the stretched monofilament is subjected to a second heat treating operation to effect the on-line shrinkage of the monofilament prior to the monofilament being equilibrated.

Claim 12

The process of claim 10 wherein the second heat treating operation is carried out at a temperature of from about 80° to about 130° C.

Claim 13

The process of claim 10 wherein the second heat treating operation results in on-line shrinkage of the monofilament for a recovery of from about 97 to about 93 percent of its stretched length.

Claim 14

The process of claim 10 wherein the second heat treating operation results in on-line shrinkage of the monofilament for a recovery of from about 96 to about 94 percent of its stretched length.

Claim 15

The process of claim 1 wherein for a suture of size 5/0 and greater, annealing in shrinkage of the suture for from about 95 to about 75 percent of its stretched length.

Claim 16

The process of claim 1 wherein for a suture of size 5/0 and greater, annealing results in shrinkage of the suture for from about 90 to about 85 percent of its stretched length.

Claim 17

The process of claim 1 wherein for a suture of size 2 to 5/0, annealing results in shrinkage of the suture for a recovery of from about 87 to about 83% of its stretched length.

Claim 18

The process of claim 1 wherein for a suture of size 2/0 to 5/0, annealing results in shrinkage of the suture for a recovery of from about 92 to about 88% of its stretched length.

Claim 19

The process of claim 10 wherein annealing results in essentially no further shrinkage of the monofilament.

Claim 20

The process of claim 1 wherein the improved property is at least one of reduced strain energy, increased knot security and reduced out-of-package set.

Claim 21

A polypropylene monofilament suture made by the process of claim 2, said suture exhibiting average strain energy parameters in the 0-5% and 0-10% strain energies which, for a given size polypropylene monofilament suture, are at least about 20% less than suture the following average strain energies in the 0-5% and 0-10% strain energy parameters: ______________________________________ Average 0-5% Average 0-10% Suture Strain Energy, parameter Strain Energy, parameter Size kg-mm kg-mm ______________________________________ 2 12.0 50 1 10.5 42 0 7.5 30 2/0 6.0 23 3/0 3.5 13 4/0 2.5 11 5/0 1.5 5.5 ______________________________________

Claim 22

The polypropylene monofilament suture of claim 20 having average maximum 0-5% and 0-10% strain energies which, for a given size of suture, are at least about 20% less than the average 0-5% and 0-10% strain energies for that size.

Claim 23

The polypropylene monofilament suture of claim 20 having average maximum 0-5% and 0-10% strain energies which, for a given size of suture, are at least about 30% less than the average 0-5% and 0-10% strain energies for that size.

Claim 24

The polypropylene monofilament suture of claim 20 having average maximum 0-5% and 0-10% strain energies which, for a given size of suture, are at least about 50% less than the average 0-5% and 0-10% strain energies for that size.

Claim 25

The polypropylene suture of claim 20, which for a given polypropylene monofilament suture are about 30% less than the average strain energies in the 0-5% and 0-10% strain energy parameters.

Claim 26

The polypropylene suture of claim 20, which for a given size polypropylene monofilament suture are about 50% less than the average strain energies in the 0-5 and 0-10 strain energy parameters.